TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

126 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Obesity / overweightHigh cholesterol

    Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

    Testing whether daily milk polar lipids affect heart and metabolic risk in adults with belly fat and

    📍 University of Connecticut · Storrs, CT · Get directions →

    The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

    ✓ Study care freeEarly Phase 1Ages 18–70Learn more →
  • Obesity / overweightHigh blood pressureHigh cholesterol

    Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

    Testing a new program after an ER visit to manage metabolic syndrome

    📍 Sidney & Lois Eskenazi Hospital · Indianapolis, IN · Get directions →

    The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care).

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

    Testing a remote mindful program to increase daily steps in people with COPD and heart failure

    📍 VA Boston · Boston, MA · +1 more US site · Get directions →

    The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF.

    ✓ Study care freeAges 40+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Passive Heat Therapy for People With COPD

    Testing whether a 45-minute hot-water footbath improves blood flow in people with COPD

    📍 University of British Columbia · Kelowna, British Columbia · Get directions →

    People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath.

    ✓ Study care freeAges 40+Learn more →
  • Obesity / overweightHigh blood pressureHigh cholesterol

    Culturally Adapted Dietary Clinical Trial in PR

    Testing a Puerto Rico–adapted diet for adults to reduce heart and diabetes risk factors

    📍 FDI Clinical Research · San Juan, · Get directions →

    This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a culturally-appropriate, feasible, and sustainable diet intervention aimed at reducing cardiovascular, type 2 diabetes, and obesity outcomes.

    ✓ Study care freeAges 30–65Learn more →
  • Heart / cardiovascular diseaseDepression

    AI Platform for Fatigue and Depression Detection

    Testing how well an AI tool can spot fatigue and depression in heart patients

    📍 Indiana University · Indianapolis, IN · +1 more US site · Get directions →

    This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.

    ✓ Study care freeAges 18–99Learn more →
  • Type 2 diabetesHigh cholesterol

    📍 Clinical Research Institute of Arizona · Sun City West, AZ · +19 more US sites · Get directions →

    This study will be a placebo-controlled, double-blind, randomized, Phase 3 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10 mg, both as a fixed-dose combination (FDC) with ezetimibe 10 mg and as monotherapy, on top of guideline-recommended lipid-lowering therapy in patients with metabolic syndrome and/or Type 2 Diabetes Mellitus.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    The Weight of Cardiovascular Disease

    Testing how a heart and metabolism clinic affects weight loss in obese adults with heart disease

    📍 Mayo Clinic in Rochester · Rochester, MN · Get directions →

    The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHigh blood pressureHigh cholesterol

    Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

    Testing step-count goals to improve body fat and heart health in adults

    📍 Kennesaw State Universityh · Kennesaw, GA · Get directions →

    The prevalence of overweight and obesity remains epidemic in the United States, with some of the highest rates seen in older adults. While this phenomenon is certainly multifactorial, a good deal of evidence suggests that insufficient physical activity (PA) contributes significantly.

    ✓ Study care freeAges 20+Learn more →
  • Heart / cardiovascular diseaseKidney disease

    The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

    Studying how kidney transplant affects tiny-heart-vessel blood flow in people with advanced chronic

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR).

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics

    Testing a digital health tool to improve weight and heart care talks in rural clinics

    📍 Washington University in St. Louis · St Louis, MO · Get directions →

    The focus on this application is low-income, rural patients, since cardiovascular disease (CVD) prevalence is 40% higher among rural than urban residents. Health behavior counseling and follow-up care are required for patients with an elevated body mass index who have increased risk for CVD.

    ✓ Study care freeAges 18–64Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

    Testing a new digital tool doctors can use to prescribe exercise

    📍 UConn Health · Farmington, CT · +2 more US sites · Get directions →

    The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators developed for physicians to use to Prioritize Personalize Prescribe EXercise (P3-EX) to patients with cardiovascular disease (CVD) risk factors. The investigators will recruit 24 physicians from two local hospitals in CT, USA.

    ✓ Study care freeAges 18–64Learn more →
  • Heart / cardiovascular diseaseKidney disease

    A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

    Testing whether orforglipron changes heart outcomes in adults with heart disease and/or kidney

    📍 Instituto de Investigaciones Clínicas Bahia Blanca · Bahía Blanca, · Get directions →

    The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.

    ✓ Study care freePhase 3Ages 50+Learn more →
  • Heart / cardiovascular diseaseDepressionAnxiety

    Improving Care and Mental Well-Being for Adults With Heart Failure

    Testing ways to improve mental well-being for adults with heart failure

    📍 Seaway Valley Community Health Centre (Cardiac Rehab Program) · Cornwall, Ontario · Get directions →

    Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives.

    ✓ Study care freeAges 40+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time

    Testing home tools and wearable devices to reduce health harms from evening screen time in people

    📍 Arizona State University · Tempe, AZ · Get directions →

    The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to reduce the negative impact that evening screen time may have on your health.

    ✓ Study care freeAges 26+Learn more →
  • Type 2 diabetesHeart / cardiovascular disease

    Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

    Testing how drinking ketone drinks affects heart function in people with type 2 diabetes and heart

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    New Heart Imaging Techniques to Evaluate Possible Heart Disease

    Testing new heart imaging to check for possible heart disease

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: \- Imaging tests, such as magnetic resonance imaging (MRI), can provide information about heart and blood vessels. The tests let doctors can see the amount of blood vessel narrowing and vessel wall thickness.

    ✓ Study care freeAges 18–100Learn more →
  • Heart / cardiovascular diseaseKidney diseaseCOPD (chronic lung disease)

    Home Hospital for Suddenly Ill Adults

    Testing home-based care for suddenly ill adults with heart, lung, or kidney conditions

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular disease

    Cereset Research Exploratory Study

    Testing Cereset Research to improve the body’s stress and sleep functions

    📍 Wake Forest University Health Scienc\ess · Winston-Salem, NC · Get directions →

    The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.

    ✓ Study care freeAges 11+Learn more →
  • Heart / cardiovascular disease

    Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)

    Testing whether a potato starch fiber supplement changes gut bacteria and short-chain fats in heart

    📍 University of Michigan · Ann Arbor, MI · Get directions →

    The study team is studying how increasing dietary fiber, specifically through adding potato starch to participant's diet, may impact the species of bacteria in participant's gut microbiome. The study team also wants to understand if adding potato starch to participant's diet helps these bacteria make more short chain fatty acids, a byproduct the team thinks may benefit participant's health.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular disease

    Improving Coronary Vascular Health in Women

    Testing whether blood flow in heart arteries can be improved in women with HIV

    📍 Massachusetts General Hospital · Boston, MA · Get directions →

    Women with HIV have an increased risk of having a myocardial infarction (heart attack) as compared to women without HIV. One of the mechanisms underlying the increased risk of myocardial infarction among women with HIV may involve reduced ability to increase blood flow through large and small coronary arteries at times when increased flow of oxygen-carrying blood is needed.

    ✓ Study care freePhase 2Ages 45–75WomenLearn more →
  • Heart / cardiovascular diseaseHigh blood pressure

    EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

    Testing a drug taken with empagliflozin in adults with type 2 diabetes and heart disease

    📍 Pinnacle Research Group, LLC · Anniston, AL · +39 more US sites · Get directions →

    This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Obesity / overweightHigh cholesterol

    Cottonseed Oil Versus Matched PUFA Effects

    Testing how cottonseed oil affects cholesterol and other risk factors in people with obesity and

    📍 University of Georgia · Athens, GA · Get directions →

    Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. Cottonseed oil (CSO) is found readily in the food supply, and the investigator's previous studies have demonstrated that incorporating CSO into the diet is sufficient to improve fasting cholesterol profile and improve postprandial lipid and/or glycemic responses in both healthy, and at-risk populations.

    ✓ Study care freeAges 25–75Learn more →
  • Heart / cardiovascular diseaseKidney disease

    Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

    Testing a machine method and staged kidney transplant during heart and kidney transplants

    📍 Cedars-Sinai Medical Center · Los Angeles, CA · Get directions →

    The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHigh blood pressureHigh cholesterol

    Complete Lifestyle Medicine Intervention Program

    Testing a complete lifestyle program for obesity, high blood pressure, and cholesterol

    📍 West Parry Sound Health Centre · Parry Sound, Ontario · Get directions →

    This project will use a mixed design and will be conducted at the West Parry Sound Health Centre. Based on similar studies there is an expected 10% drop-out rate so 20 participants per group will be invited to aim to have 15 finish.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility

    Survey to check eligibility for obesity and heart-related clinical trials

    📍 Brooklyn Clinical Research · Brooklyn, NY · Get directions →

    SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseKidney disease

    Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

    Testing whether sotagliflozin can slow kidney damage in type 1 diabetes

    💵 May compensate

    📍 Stanford University Medical Center · Stanford, CA · +12 more US sites · Get directions →

    Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because of the few studies in this population, due to concerns about the increase in risk of diabetic ketoacidosis (DKA, a serious, potentially fatal acute complication of diabetes due to the accumulation of substances called ketone bodies) observed with SGLT2i therapy in T1D.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Heart / cardiovascular diseaseHigh blood pressureKidney disease

    SPYRAL GEMINI Pilot Study

    Testing whether a device that treats nerves in multiple organs is safe and lowers blood pressure in

    📍 Stanford Hospital and Clinics · Stanford, CA · +11 more US sites · Get directions →

    The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

    ✓ Study care freeAges 18–80Learn more →
  • Heart / cardiovascular diseaseKidney disease

    Feasibility of The Health Integrated Nutrition and Kidney Wellness Program

    Testing whether a nutrition and kidney health program is workable for adults with kidney disease

    📍 UPMC Kidney Clinic - Wexford · Pittsburgh, PA · +4 more US sites · Get directions →

    Purpose of the Study: This clinical trial will test whether a nutrition and kidney health program can work well for adults with kidney disease. The program was created with help from patients and community partners.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular disease

    The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health

    Testing whether drinking Chardonnay grape marc affects gut and heart health

    📍 University of California, Davis · Davis, CA · Get directions →

    Recently a dietary recommendation of 400 - 600 mg/ day has been proposed for the reduced risk of developing cardiovascular disease. Dietary flavanols can be obtained from the intake of foods such as tea, cocoa, wine, berries and apples.

    ✓ Study care freeAges 45–70WomenLearn more →
  • Heart / cardiovascular diseaseHigh blood pressureHigh cholesterol

    Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

    Testing a pharmacy-led plan to help people take medicines after hospital discharge

    📍 University of Tennessee Medical Center · Knoxville, TN · +1 more US site · Get directions →

    Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of readmissions and costs among these patients.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    Inspire HER: Inspiring the Heart and Emotions for Radical Health

    Testing a heart-health lifestyle program for Black women with poor health

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    Poor heart health puts Black women at risk for a shorter life with more illness than people of any other non-indigenous racial group. We will refine and conduct a randomized, wait-list controlled trial of Inspire HER (a heart health lifestyle intervention for Black women that provides health education, physical activity, and social resources).

    ✓ Study care freeAges 30–79WomenLearn more →
  • Obesity / overweightHeart / cardiovascular disease

    Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

    Testing whether semaglutide changes heart risk markers in teens with severe obesity

    📍 University of Kentucky · Lexington, KY · Get directions →

    The goal of this clinical trial is to learn if the drug semaglutide changes markers of disease risk as it relates to weight in children ages 12-15 years old who are obese (class 2 or 3). The main questions it aims to answer are: * How do the rate of weight loss, body mass index (BMI), body composition, heart structure and function, and exercise ability interact with one another in the study population at enrollment?

    ✓ Study care freeAges 12–17Learn more →
  • Obesity / overweightHigh cholesterol

    Intermittent Cottonseed Oil Consumption

    Testing intermittent cottonseed oil in people with obesity and high cholesterol

    📍 University of Georgia · Athens, GA · Get directions →

    Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. Cottonseed oil (CSO) is found readily in the food supply, and the investigator's previous studies have demonstrated that incorporating CSO into the diet is sufficient to improve fasting and postprandial blood lipids and other markers of chronic disease risk in both healthy and at-risk populations.

    ✓ Study care freeAges 25–75Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling in Rural Primary Care Clinics

    Testing a digital tool to improve health counseling for obesity and heart health in rural clinics

    📍 Washington University in St. Louis · St Louis, MO · Get directions →

    This project will conduct a pilot hybrid study that examines the implementation (Aims 1 \& 2) and preliminary effectiveness (Aim 3) of PREVENT, a digital health intervention, among patients with overweight/obesity (N=100) using a clinic-randomized design. The central hypothesis of the study is that PREVENT will be feasible and show improvements in health behavior counseling and the patient experience that will improve patients' motivation to change, and their CVH health behaviors and outcomes.

    ✓ Study care freeAges 18–64Learn more →
  • Heart / cardiovascular diseaseLupus (SLE)

    The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD

    Testing whether anifrolumab improves blood vessel risk markers in lupus

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart attacks or stroke.

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Prevention of Progression of Prediabetes, Obesity and CV Risk

    Testing ways to stop prediabetes and obesity from getting worse

    💵 May compensate

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    The investigators are studying how to help people with prediabetes (Pre-DM) and obesity. The goal is to use new and affordable treatments to bring blood sugar levels back to normal and help participants to lose weight.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children

    Testing whether whole or nonfat milk changes body composition in children

    📍 New Balance Foundation Obesity Prevention Center · Boston, MA · Get directions →

    This study will evaluate the effects of whole vs. nonfat milk consumption on body composition, cardiometabolic disease risk factors, and dietary quality.

    ✓ Study care freeAges 9–12Learn more →
  • Type 2 diabetesHeart / cardiovascular diseaseKidney disease

    Food and Fitness With Medicine (FFWM)

    Testing a food and fitness program to reduce stopping type 2 diabetes medication in postmenopausal

    📍 Ohio State Healthy Community Center · Columbus, OH · +3 more US sites · Get directions →

    Food and Fitness with Medicine (FFWM) is a 24-week randomized controlled trial (RCT) enrolling 200 post-menopausal women (PMW) with stage 2 cardio-kidney metabolic (CKM) syndrome and type-2 diabetes (T2D) within 6 weeks of initiating glucagon-like peptide-1 receptor agonist (GLP-1RAs) to: 1. Examine discontinuation rates of GLP-1RAs (primary outcome); 2.

    ✓ Study care freeAges 18+WomenLearn more →
  • High blood pressureHigh cholesterolCOPD (chronic lung disease)

    Interprofessional Pharmacogenomics (IPGx) Registry and Repository

    Collecting genetic and health data to guide medication choices for people with high blood pressure,

    📍 Texas A&M Family Care · Bryan, TX · Get directions →

    This program collects genetic and health information to help doctors choose the right medications for patients.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

    Testing whether maridebart cafraglutide lowers heart risks in people with heart disease and obesity

    📍 Alliance For Multispecialty Research - Daphne · Daphne, AL · +39 more US sites · Get directions →

    The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.

    ✓ Study care freePhase 3Ages 45–99Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

    Testing maridebart cafraglutide with standard care to reduce heart failure events in obese people

    💵 May compensate

    📍 University of Alabama Saint Vincent's Birmingham · Birmingham, AL · +39 more US sites · Get directions →

    This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fraction (HFpEF) and HF with mildly reduced ejection fraction (HFmrEF) who are obese. This is a phase 3, global, multicenter, 2-part trial with a double-blind period and an open-label extension (OLE).

    ✓ Study care freePhase 3Ages 18–99Learn more →
  • Heart / cardiovascular diseaseDementia / Alzheimer's

    100-Year Human Aging Study

    Studying how health measurements predict death, major illness, and disability over a lifetime

    📍 Longevity Metrics · Boulder, CO · Get directions →

    The 100-Year Human Aging Study is a prospective, pragmatic, observational trial enrolling participants across fixed and mobile clinical sites to undergo comprehensive multi-system health screening and longitudinal follow-up until death. Participants are followed to determine whether measurements taken at enrollment and repeated across the lifespan - individually and in combination - predict all-cause mortality, cause-specific mortality, incident serious disease, and functional disability.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular disease

    Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes

    Testing whether a genetic risk test helps improve heart-kidney outcomes in type 2 diabetes

    📍 CHUM · Montreal, Quebec · Get directions →

    The goal of this pragmatic trial is to provide Real World Evidence (RWE) on the impact of the result of a polygenic risk prediction test of cardiorenal complications of T2D, so that more patients at high risk of these complications achieve over an 18 months period, recommended therapeutic targets. This will be demonstrated as a significant improvement in a composite value including HbA1c or systolic blood pressure (SBP) or albuminuria (UACR), or glomerular filtration rate (GFR) lowering.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

    Testing how well NNC0487-0111 works versus placebo in heart failure with excess body weight

    📍 Advanced Cardiovascular, LLC · Alexander City, AL · +39 more US sites · Get directions →

    This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have HFpEF or HFmrEF and excess body weight.

    ✓ Study care freePhase 3Ages 18+Learn more →
  • Heart / cardiovascular disease

    Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

    Testing an EHR tool that flags heart failure risk in people with type 2 diabetes

    📍 UT Southwestern Medical Center · Dallas, TX · Get directions →

    A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.

    ✓ Study care freeLearn more →
  • Obesity / overweightHeart / cardiovascular diseaseKidney disease

    The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity

    Studying how obesity and HFpEF are linked to chronic kidney disease

    📍 University of Mississippi Medical Center · Jackson, MS · Get directions →

    This research study wants to learn about Chronic Kidney Disease (CKD) with Obesity, and Heart Failure with preserved Ejection Fraction (HFpEF) and better ways to evaluate these diseases. HFpEF means that the heart is not able to fill properly with blood while it is resting so the amount of blood pumped out to the body is less than it would be if it was filling properly.

    ✓ Study care freeAges 18–75Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)Heart / cardiovascular disease

    Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

    Checking whether lab tests and research tools give accurate, repeatable results for chronic disease

    📍 University of Missouri-Columbia · Columbia, MO · Get directions →

    The purpose of this research study is to validate (check the accuracy of) laboratory assays, intravenous catheter insertion, and equipment or devices and their reproducibility, which is necessary to perform high quality research on chronic diseases, nutrition, and metabolism (the process by which a substance is handled in the body) at the University of Missouri. As technology changes and uses new testing methods, it is necessary to compare results from old tests, equipment and devices and new tests, equipment, or devices and the reproducibility of these measurements to make sure the results are accurate.

    ✓ Study care freeAges 18–100Learn more →
  • High blood pressureHigh cholesterol

    Imaging the Pathogenesis of Cerebral Small Vessel Disease

    Studying how high blood pressure and cholesterol relate to brain small-vessel damage seen on MRI

    📍 Kennedy Krieger Institute · Baltimore, MD · Get directions →

    Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightType 2 diabetesHeart / cardiovascular disease

    📍 Clindove Research LLC · Brooklyn, NY · Get directions →

    DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseDementia / Alzheimer's

    Human Observatory Study

    Tracking how health conditions like heart disease and dementia relate

    📍 Longevity Metrics · Boulder, CO · Get directions →

    The Human Observatory Study is a prospective observational and ecological surveillance study building a continuously-updating world model for human health, disease, and death at the individual and population level. Individual multi-system clinical data from enrolled participants are linked to a continuously-ingested ecological data infrastructure spanning environmental exposures, social determinants, genealogical and family history records, mortality data, and population health databases at geographic resolutions from home address to global scale and beyond.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure

    Testing a 6-month coaching and exercise program to improve heart health in people with low income,

    📍 Johns Hopkins Center for Health Equity · Baltimore, MD · +1 more US site · Get directions →

    This study aims to determine whether a 6-month multilevel intervention involving problem-solving training, exercise training and support from community health workers is more effective in improving outcomes for individuals with low socioeconomic status, type 2 diabetes, obesity, and early cardiac dysfunction than receiving education and access to a community exercise facility.

    ✓ Study care freeAges 30–70Learn more →
  • Type 2 diabetesHeart / cardiovascular diseaseHigh blood pressure

    Military Health and Nutrition Examination Study

    Assessing food intake, health, and nutrition markers in service members

    📍 Fort Campbell · Fort Campbell, KY · +2 more US sites · Get directions →

    The Military Health and Nutrition Examination Study (MHANES) is a Department of Defense funded study conducted by Pennington Biomedical Research Center and the US Army Research Institute of Environmental Medicine. This cross-sectional study will assess, in a large, diverse sample of Army Service Members (n=600), food and supplement intake, cardiovascular health, body composition, biomarkers of nutritional status, measures of health status, injury prevalence, mental wellbeing, gut microbiome composition, and physical performance outcomes.

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHigh blood pressureHigh cholesterol

    Healthy Living Anson Study

    Testing whether meal and education support improves diet quality in adults with obesity and blood

    📍 University of North Carolina at Chapel Hill · Chapel Hill, NC · Get directions →

    The goal of this randomized delayed control intervention research study is to see if participants who receive education and healthy prepared meals improve the quality of their diet compared to participants who receive only physical activity education and coaching.

    ✓ Study care freeAges 18–99Learn more →
  • Heart / cardiovascular disease

    EVOC - EVs in Obesity and Cardiometabolic Disease

    Studying how tiny cell sacs from heart, liver, and fat relate to heart risk and type 2 diabetes

    📍 Massachusetts General Hospital · Boston, MA · Get directions →

    The goal of this observational study is to research the impact of molecular signals from the heart, liver and fat tissue on cardiovascular disease risk, and the presentation of Type II Diabetes and diseases that affect the heart, blood vessels and metabolism (Cardiometabolic Disease). Specifically, the focus is on the content and function of Extracellular Vesicles (EVs), small sacs released from a cell's surface that contain important molecular cargo.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular disease

    COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

    Testing colchicine and plain aspirin, alone or together, for heart outcomes in high-risk type 2

    📍 Curtin University · Bentley, Western Australia · Get directions →

    To evaluate the efficacy and safety of colchicine and non-enteric coated aspirin, combined or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes.

    ✓ Study care freePhase 3Ages 55–80Learn more →
  • Heart / cardiovascular diseaseKidney disease

    Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

    Testing an AI chat and home vital-sign monitoring plan for heart, kidney, and metabolic health

    📍 Fountains Family Care · Chandler, AZ · +3 more US sites · Get directions →

    The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an algorithm obtained from biomarkers and diagnostics utilizing remote sensor driven technology tools, care coordination and patient empowerment.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseKidney disease

    Feasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid

    Testing an online tool to help people with chronic kidney disease and heart disease make health

    📍 Foothills Medical Centre · Calgary, Alberta · Get directions →

    Many people with kidney disease also have heart disease. The procedures used to diagnose and treat heart disease (e.g., angiograms, angioplasty, or surgery) can improve symptoms and cardiovascular outcomes, but pose greater risks of kidney complications for people with chronic kidney disease.

    ✓ Study care freeAges 18+Learn more →
  • High cholesterol

    A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

    Testing how safe and well weekly injections of alirocumab work for high cholesterol in adults

    📍 Anaheim Clinical Trials · Anaheim, CA · +29 more US sites · Get directions →

    This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the treatment of hypercholesterolemia (high blood cholesterol levels).

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Heart / cardiovascular disease

    Investigating the Combined Effects of Protein, Blueberries, and Exercise on Cardiovascular Health and Frailty in Older Nova Scotians

    Testing how protein, blueberries, and exercise affect heart health and frailty in older adults

    📍 QEII Health Sciences Centre, Dickson Building · Halifax, Nova Scotia · Get directions →

    Cardiovascular diseases (CVD) are a leading cause of morbidity and mortality worldwide. While CVDs are predominantly diseases of aging, age itself does not predict CVD risk; people age at different rates.

    ✓ Study care freeAges 65+Learn more →
  • Showing the first 60 of 126. Add filters or a location to narrow down.